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Abstract
Deaf American Sign Language (ASL) users represent a small population at risk of marginalization 
from research and surveillance activities as a result of cultural, language, and ethical challenges. 
The Deaf community's view of deafness as a cultural identity, rather than a disability, contradicts 
the medical community's perception of deafness as a disease or deficiency in need of correction or 
elimination. These differences continue to have significant cultural and social implications within 
the Deaf community, resulting in mistrust of research opportunities.
Two particularly contentious ethical topics for the Deaf community are the absence of community 
representation in genetic research and the lack of accessible informed consents and research 
materials. This article also outlines a series of innovative strategies and solutions to these issues, 
including the importance of community representation and collaboration with researchers studying 
Deaf populations.
Cultural naïveté and lack of language fluency create a host of barriers and ethical dilemmas 
for many health researchers who work with minority, underserved, and vulnerable 
populations. Collaborating with underrepresented communities requires researchers to 
demonstrate creativity, mutual respect, flexibility, compassion, cultural competency, and 
patience in their work. Deaf American Sign Language (ASL) users comprise a population of 
particular concern due to the marginalization they face as a result of communication, 
cultural, social, and language barriers. These challenges have historically isolated the Deaf 
community from a variety of beneficial health education and outreach programs, disease 
surveillance, and health research resulting in health inequities and limited health care 
access.1-7
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Few health researchers understand the cultural values held by the Deaf community or know 
ASL. The lack of linguistic and cultural concordance places the population at high-risk for 
poor research engagement and inaccessible informed consent processes and research 
materials. This perpetuates a long-standing history of fear, mistrust, and frustration of Deaf 
ASL users with biomedical research.8
The Deaf ASL community refers to Deaf individuals who use ASL as their primary 
language, and constitute a group of individuals who identify themselves as a minority entity, 
with their own unique language and culture.9,10 Deaf ASL users share a set of values, 
customs, attitudes, and experiences that contrast with the hearing world.13 ASL is 
commonly misunderstood to be a gestural language or a visual “English” language 
representing spoken English. ASL contains its own syntax and language structure, which is 
distinct from English and does not have a written form. Approximately 500,000 Deaf ASL 
users are estimated to live in the United States.11,12
Despite increasing evidence of substantial health disparities within this population, the Deaf 
ASL community is largely under-studied and underserved. Deaf ASL users rarely participate 
in clinical research and surveillance activities in part due to: exclusion criteria, inaccessible 
informed consent processes, inadequate recruitment and engagement strategies, and 
culturally misguided genetic testing and engineering.13-16 The principles of justice, respect 
for persons, and beneficence behooves public health researchers to address existing health 
inequities by promoting access and collaboration with Deaf communities. This paper 
follows the principles of ethical theory in outlining two key ethical issues along with 
potential strategies for health researchers to increase participation opportunities for Deaf 
ASL users to benefit from clinical research and surveillance efforts. The authors hope the 
paper will help researchers better understand the perspectives of Deaf community members 
on biomedical research.
The Fear of Genetic Testing and Engineering
Historically, deafness-related research has tended to focus on the elimination of deafness 
through the use of medical technologies and genetic engineering.9,14 The eugenics 
movement (1880-1950) in the United States, Great Britain, and Germany provided some 
degree of moral permissibility of sterilizing deaf people with the intent of reducing “social 
burdens” and increasing the health of the human species through “better breeding.”10,17,18 
Another movement called oralism, popularly promoted by Alexander Graham Bell, 
prioritized human speech over sign language and incorporating the use of speech reading 
and hearing amplification.10,19 The lasting impact of the Eugenics and oralism movements 
and advancing medical technologies (e.g. success of hearing aid use and cochlear implants) 
have led to society's negative perception of deafness as a disability, rather than as a cultural 
identity.10 The focus on deafness as a disability (i.e. the “medical model” of deafness) 
conveys conflicting values and the sense of inferiority to many deaf children and 
adults.9,20,21
Despite mostly well-intentioned efforts by health researchers and providers to mitigate or 
prevent hearing loss, deafness should not be viewed simply as a disease or disability, but 
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rather, from the community's perspective, as a unique feature or identity (e.g. skin color, 
height, or sexual orientation). Nowhere is this cultural clash more visible than in the 
advancement of genetic testing and engineering. The palpable threat of genetic testing and 
engineering to the Deaf community is unique to this minority population. There are no 
known genetic research studies that provide the potential elimination of a cultural attribute 
or phenotype valued by a particular minority or cultural group.
Despite the predominance of research on genetic etiologies of deafness and its syndromes, 
the Deaf community rarely receives an opportunity to express its views.22,23 By failing to 
fully engage the Deaf community in dialogue about such findings and the research agenda, 
such research fuels fears that consequential genetic engineering may result in a substantial 
reduction of the number of congenitally Deaf individuals through prenatal genomic testing 
and genetic counseling.24,25 Approximately 75–80% of the more than 400 identified deaf 
genes are recessive, with a smaller proportion being autosomal dominant (20%) and X-
linked (2–5%), 2627 which results in a high proportion of deaf individuals born to hearing 
parents. The Deaf community has well-founded fears that prenatal screening could permit 
the opportunity for hearing parents to terminate pregnancies and/or elect the use of genetic 
engineering to avoid the birth of a deaf infant. The potential loss of future Deaf individuals 
has major implications for the viability of the Deaf culture.
The acquisition of ASL and Deaf culture is generally through peer-exchanges and Deaf 
schools (i.e. “horizontal cultural transmission”) and less so from parents (i.e. Deaf parents of 
Deaf children).20 Horizontal cultural transmission differs from other minority populations, 
whose parents primarily transmit and share a similar language and cultural values to their 
children (i.e. through “vertical cultural transmission”).20 Hearing parents, clinical providers, 
and medical researchers may lack familiarity with the Deaf community, further placing Deaf 
members at risk for medical and cultural misunderstandings. Middleton et al. (2001) found 
that hearing individuals are much more accepting of conducting prenatal testing to 
determine the presence of hearing loss than are Deaf individuals (49% versus 21%).28 The 
lack of acceptance of testing reflects the ongoing mistrust of the medical community by 
Deaf individuals and the predominate notion held by the majority hearing population that the 
deafness is defective. Thus, the disconnect between the Deaf and hearing communities and 
much of the medical establishment involved with hearing testing, treatment, and counseling 
poses a continual risk to the Deaf community and fuels mistrust.
On the other hand, genetic research can benefit the Deaf community through the recognition 
of certain types of hereditary deafness associated with the risk of particular health outcomes. 
For example, some syndromic forms of deafness are associated with retinitis pigmentosa 
(e.g. Usher Syndrome), craniofacial dysmorphia (e.g. Treacher-Collins syndrome), long QT 
syndrome (e.g. Jervell and Lange-Nielsen syndrome), and renal abnormalities (e.g. Alport 
syndrome). There is even new recognition that certain deaf genes may even offer positive or 
protective effects against other conditions (e.g. Pendred syndrome appears to confer 
protection to Deaf individuals against hypertension and asthma).29
The majority of genetic causes of deafness are non-syndromic (e.g. Connexin 26), however, 
resulting in no other known health risk for Deaf individuals.30 Research in deaf genetics is 
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complex, given the diversity of etiologies and syndromes, and the relatively high proportion 
of all human genes associated with hearing mechanisms (i.e. 1% of all human genes).30
Increasing Community Representation in Genetic Research
Population-based research needs to engage the Deaf community to learn about priority areas 
of research to improve health disparities and the social impact of the research on the Deaf 
community. The Deaf ASL community may hold different expectations and needs than what 
many researchers may anticipate. Deaf individuals are often aware of the biologic basis for 
some of their health differences but their focus frequently differs from researchers (i.e. 
existing health and social inequities, rather than deafness itself). It is critical that Deaf 
community members be encouraged to participate on community boards, research review 
committees, and research grant agencies to ensure appropriate cultural, linguistic, and 
ethical representation to ensure beneficence is achieved.
Furthermore, Deaf ASL users hold unique social and communication cultural norms,20,31 
which pose challenges for researchers to understand without directly engaging themselves in 
the community through a variety of actions (e.g. becoming fluent in ASL, attending deaf 
related events, respecting the Deaf cultural model). Researchers working with Deaf ASL 
users should ensure a presence in the community, including at important cultural events and 
relevant organizations to earn trust and credibility. Solutions within the Deaf community 
include researchers taking ASL classes, working closely with Deaf gatekeepers, and 
providing opportunities for community members to learn about relevant health topics and 
research.14
For example, Gallaudet University, a Deaf university, and the University of California Los 
Angeles conducted a variety of genetic research and counseling programs with a bicultural 
team of hearing and Deaf researchers and staff.32,33 A research team consisting of Deaf 
researchers and staff can provide an additional element of cultural and language 
accessibility, in addition to trust, frequently necessary when researching complex or 
sensitive topics. Their particular research programs generated great interest among Deaf 
individuals across the country to not only identify deaf genes, but also to allow the 
researchers to explore the societal impact of advancing genetic testing on the Deaf culture.33 
In accord with the ethical principle of beneficence, the key is to ensure that genetic research 
in hereditary deafness maintains its focus on the acquisition of scientific knowledge and 
improvement of deaf people's health, not simply on the elimination of deaf people.21
Inaccessible Informed Consent
Informed consent requires that individuals receive adequate information to be able to make 
an informed decision to participate in research, that individuals understand the information 
provided, and that they are individuals able to make a voluntary decision.34 Unfortunately, 
standard informed consent processes generally rely on written English forms, which are 
mostly ineffective for Deaf ASL users for multiple reasons. First, many Deaf ASL users 
often fail to accumulate factual knowledge resulting in significant gaps in basic information 
and limited “fund of information.”21,35 The information gap occurs as a result of their 
inability to access auditory-based information and the scarcity of information resources 
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available in ASL.20,21 Average written English proficiency36 and health literacy35 among 
Deaf ASL users are lower than the general population, which further precludes them from 
interacting with hearing researchers or asking questions during the informed consent 
process. Furthermore, the majority of informed consents are written at a level that requires a 
high school education or higher37 which is problematic given 20% of deaf individuals have 
demonstrated fluency in written English,38 and the average English reading level of deaf 
high school seniors is at or below a 4th-grade level.36 The lack of comprehension can impair 
potential Deaf subjects’ ability to truly consent and participate voluntarily in research.
Secondly, even among non-native English speakers with high educational attainment and 
good English proficiency, many individuals still require further explanation of the informed 
consent contents to achieve adequate comprehension.39 Language and communication 
barriers play a significant role in creating difficulties in obtaining true consent among the 
general population. In one study, 40% to 80% of hearing English speakers with the capacity 
to consent still did not understand one or more aspects of the consent content,40,41 whereas 
in another study 30% of consented research participants were completely unaware of their 
research involvement.42 For limited English proficiency (LEP) populations, including Deaf 
ASL users, comprehension of research activities is thought to be much lower due to both 
language discordance and poorer health literacy. Even with the availability of on-site 
professional interpreter services, Schenker et al. (2007) found that Chinese- and Spanish-
speaking hospitalized patients who do not speak English are less likely to have 
documentation of informed consent for common invasive procedures. 43
Federal regulations governing human subjects research dictate “the information that is given 
to the prospective subject or the representative shall be in a language understandable to the 
subject or the representative.”4413,35,45 Sudore et al. (2006) demonstrated that to maximize 
the likelihood that consent information will be understood, informed consent should be 
delivered in the subjects’ native language, regardless of proficiency in English.39 It is 
difficult to address the complexity of health communication and informed consents without 
a first-hand knowledge of the targeted community's native language and cultural customs, 
norms, and values.37,39,46,47 Unfortunately, very few studies evaluate informed consent 
processes and comprehension among those with limited English proficiency populations 
while none are available for Deaf ASL users.48,49 This is concerning since many researchers 
and providers erroneously assume that ASL is based on English and that Deaf ASL users are 
proficient in written English and speech reading.1,38,50 In addition to communication 
barriers, Deaf ASL users lack a written language which largely precludes many from the 
ability for them to simply read a translated informed consent. The lack of a written language 
is a unique challenge that places the Deaf population at additional risk apart from other 
minority populations.
Informed consent processes with Deaf ASL users need to be visualized in a much broader 
format than the commonplace written English consent forms. The use of language-
concordant, accessible short videos and visual formats that do not rely on prose increase 
accessibility of informed consent forms. Joseph et al. (2006) and Murphy et al. (1999) 
demonstrated improvements in the recall ability and comprehension of consenting hearing 
participants with short videos and the use of pictures in their informed consents.51,52 Sudore, 
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et al. (2006) also found that additional education (i.e. “teach to goal”) through the use of an 
interactive and educational strategy helped subjects to fully understand the necessary 
information, regardless of their educational attainment, language fluency, and social 
backgrounds.39 Similarly, Kripilani et al. (2008) successfully utilized “teach-back” methods 
in informed consents with low-literacy groups.53
Culturally Appropriate Strategies to Improve Informed Consent Processes
When possible, research staff should be fluent in the populations’ native language and, if 
possible, be familiar with the culture of the population as well to help reduce mistrust, 
anxiety, and confusion during the consent process. These efforts have improved 
understanding and trust among Deaf individuals enrolled in studies affiliated with the 
National Center for Deaf Health Research (NCDHR) at the University of Rochester. 
Researchers at the NCDHR collaborate closely with their community partner, the Deaf 
Health Community Committee (DHCC), which consists of 15-18 representatives from the 
Rochester Deaf community to develop innovative ways to improve the comprehension of 
research materials and informed consents. Deaf subjects who enroll in NCDHR-based 
research studies receive informed consents in easy-to-read written English and either in ASL 
by a video or through an ASL-fluent research staff member. A critical step was the 
realization of the importance to present informed consent process in a dialogic fashion to 
improve both retention of information and ease of communication between the subject and 
the research team.54,55
This dialogic approach incorporates the traditional format of ASL story-telling between two 
Deaf individuals. As Pollard, et al. (2009) demonstrated, the key information outlined in an 
English document (i.e. informed consent form) is adapted and translated into an ASL script. 
Difficult to understand information is discussed in a conversational style between two or 
more Deaf actors.16,56 The dialogic approach generates a short movie or a novella that is 
engaging, educational, and culturally affirmative, yet which conveys the same essential 
points found in the source material.
Informed consent, similar to other questionnaires and study materials, should be developed 
and piloted collaboratively with a community partner to ensure that the targeted population 
would understand the contents. The NCDHR and the DHCC partnered together to provide 
linguistic and cultural guidance and feedback on the informed consents and relevant 
research materials. This model of community-based participatory research (CBPR) provides 
an opportunity to address health issues in a variety of understudied minority populations, 
including Deaf ASL users.7,14,57-59 CBPR integrates educational and social action in 
research through the active and equitable involvement of community members and 
researchers.60 Benefits of CBPR include the empowerment of the community's ability to 
vocalize and address its health needs, the use of community's strengths and resources to 
initiate and conduct research, and the recognition of the community as a partner in research 
and public health.61 The community is also provided an opportunity to share any 
reservations or concerns they may have regarding the informed consent processes or other 
aspects of research conduct.
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Conclusion
Although many research studies involving Deaf and hard of hearing populations are 
associated with hearing loss and genetic research, the Deaf community, similar to many 
other minority populations, struggles with a number of socio-economic based health 
disparities, many of which are not directly associated with hearing loss. The Deaf 
community's health priorities may drastically differ from the goals of health researchers 
studying Deaf populations. Deaf community members should be provided with opportunities 
to vocalize or represent their community in agenda setting research meetings. It is critical 
that health researchers work closely with community members and organizations to learn 
about the health inequities that need to be addressed. Health research should ensure 
accessible research materials, including informed consent documents. Increasing 
accessibility of research studies to smaller populations such as the Deaf community helps to 
generate more representative findings while improving the equity of those who benefit from 
the advancement of health research.
Diversity in our population, regardless of race, ethnicity, language, culture, values, and 
hearing loss needs to be protected and respected in our health care and medical research 
settings. A more collaborative approach, using the principles of CBPR, beneficence, and 
justice, will allow for mutual respect between health researchers and the Deaf community 
and provide avenues for more culturally affirming health research to occur.
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